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ABSTRACT 
Apoptosis is an important cellular physiological function to continually balance 
the cell proliferation with cell death to maintain the healthy internal milieu. This 
study assessed the ability of Curcumin to inhibit 3T3-L1 adipocytes viability and 
its effects on apoptosis to identify a potential molecular approach for preventing 
adipocytes growth. To optimize the growth inhibitory concentration, 3T3-L1 
adipocytes treated with different concentrations of Curcumin (5, 10, 20, 
40, 60, and 80 μM) for 24 hours, and were analyzed by MTT and found 40 μM as 
an optimal dose. Cell cycle was analysed by FACS using the optimal dose for 
different periods (4-24h). Western blot was carried out using antibodies to detect 
protein expression and Phosphorylation of Adiponectin, AMPK, CREB, PKA 
catalytic subunit, and Akt. PKA relative activity and ROS generation was also 
assessed by DCFHDA fluorescence. The findings of the study revealed that 
Curcumin has successfully arrested 3T3L1 adipocytes cycle and exerted apoptotic 
action on the cells in a concentration- time dependent manner; increased 
Adiponectin expression; activated phosphorylated AMPK (p-AMPK) and inhibited 
PKA activation. Curcumin prevented the production of ROS generation. Results 
indicate that Curcumin exerts a very potent apoptotic action on 3T3L1 adipocytes 
and modulates adiponectin expression and AMPK and PKA signalling. These 
findings lead us to further investigate and support the potential use of Curcumin 
therapy in obesity resistance. 
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RESUMEN 
La curcumina inhibe la viabilidad celular e induce la apoptosis mediante la 
modulación de la adiponectina, la AMPK y PKA en adipocitos 3T3-L1 
La apoptosis es una función fisiológica celular importante para equilibrar de 
manera continua la proliferación y la muerte celulares con el objeto de mantener 
el entorno interno sano. Este estudio se determina la capacidad de la curcumina 
de inhibir la viabilidad de los adipocitos 3T3-L1 y sus efectos sobre la apoptosis 
para identificar un posible acercamiento molecular para prevenir el crecimiento 
de los adipocitos. Para optimizar la concentración inhibitoria del crecimiento, los 
adipocitos 3T3-L1 han sido tratados con diversas concentraciones de curcumina 
(5, el μM 10, 20, 40, 60, y 80) durante 24 horas y analizados por MTT, 
encontrando el μM 40 como dosis óptima. El ciclo de la célula ha sido analizado 
por FACS usando la dosis óptima en diversos períodos (4-24h). El Western blot se 
realizó usando los anticuerpos para detectar la proteína y la fosforilación de la 
adiponectina, de la subunidad catalítica de AMPK, de CREB, de PKA, y de Akt. La 
actividad relativa de PKA y la generación del ROS también fueron determinadas 
por fluorescencia de DCFHDA. Los resultados del estudio revelaron que la 
curcumina ha detenido con éxito el ciclo de los adipocitos 3T3L1 y que la acción 
apoptótica ejercida en las células en una concentración mide el tiempo de manera 
dependiente; expresión creciente de adiponectina; AMPK fosforilado activado (p-
AMPK) y activación inhibida de PKA. La curcumina previno la producción de la 
generación del ROS. Los resultados indican que la curcumina ejerce una acción 
apoptótica muy potente en los adipocitos 3T3L1 y modula la expresión de la 
adiponectina indicando AMPK y PKA. Estos resultados nos conducen a ir más lejos 
en la investigación y el uso potencial de la terapia de la curcumina para combatir 
la obesidad. 
Palabras clave: Apoptosis; 3T3L1; curcumina; adiponectina; AMPK; PKA. 
1. INTRODUCTION 
The possibility of managing cell survival and death has great therapeutic 
potential given the importance of cell cycle transition and apoptosis in the 
physiological functions of cells (1). The inhibition of differentiation, adipogenesis, 
angiogenesis and stimulation of physiological apoptosis in adipocytes in vitro or in 
vivo may be a potential strategy to inhibit adipose cell expansion and growth, thus 
preventing obesity and associated disorders. It has recently been discovered that 
adipose tissue is a hormone-secreting organ that releases adipokines, such as 
leptin, adiponectin, and visfatin. As such, adipose tissue is a principal of both the 
endocrine and immune systems (2). 3T3L1 cells are considered to be an excellent 
model to study adiposity because Adiponectin is primarily distributed in 
microvesicle particles of adipocytes (3). Many factors include curcumin could 
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modulate leptin release from 3T3L1cells  (4, 5).  Different mechanisms for 
physiological and pathological apoptosis processes have been investigated, 
including suppressing signal transduction pathways to stimulate apoptosis (6). 
Cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKA) 
functions as both a suppressor and activator of apoptosis. In arterial smooth 
muscle cells adenosine-mediating apoptotic pathways are activated (7);  however, 
Zhang et al, (8) reported that the cAMP signalling pathway has been found to 
either support or inhibit apoptosis, depending on cellular situation. The adipokine 
leptin inhibits growth via apoptosis caused by adenylate cyclase/cAMP/PKA-
elevating agents in some cancer cells (9). Increase in weight is resulted due to the 
growth and enlargement of adipose tissue, and AMPK is a major controller of 
energy metabolism that increases fatty acid oxidation and suppresses lipid 
accumulation (10,11).  Mihaylova and Shaw (12) reported that in addition to 
physiological AMP/ADP elevation stresses, AMPK can be stimulated by many 
pharmacological agents and factors, including leptin, and AMPK in turn can 
suppress cell growth by acting as a metabolic check point. AMPK also directly 
phosphorylates some regulatory associated proteins and reduces expression of 
cAMP response element-binding protein (CREB) targets, which is important since 
CREB activation stimulates the expression of multiple transcription factors 
required for adipogenesis (13). Reactive oxygen species (ROS) and mitochondria 
play a prominent role in apoptosis as described by Simon et al. (14). Recently, it 
was found that apoptosis is regulated by ROS through a variety mechanisms 
depending on cell and conditioned media types (15). Adipose tissue growth is 
sensitive to angiogenesis and adipogenesis inhibitors (16), as well as adipokines 
(2) and these may serve as effective tools for controlling adipocytes growth. 
Curcumin was reported as a potent inducer for apoptosis characteristics, 
including cell fading, chromatin retraction, DNA fragmentation, and cell membrane 
blebbing (6). The anti-angiogenic effect of curcumin in vivo was supported by its 
action at the level of gene expression in modified media of cells treated with 
different doses of curcumin (1 μM–1 mM) for various time durations (0–24 h) (17) 
. Curcumin has been studied for its potential effect in antiangiogenic activity in 
tumor (18) and in preventing obesity in C57BL mice and inhibiting adipogenesis in 
3T3-L1 adipocytes (16) as well as cancers (19- 21). In contrast, Kim et al (22) 
found that low concentration of curcumin activated proliferation, improved 
stemness and migration of 3T3-L1 preadipocytes. Cellular survival required 
Protein Kinase B (PKB or Akt1) through its inhibiting effect on apoptosis so it is 
 involved as principal factor in multiple cancers (23). But curcumin was able to 
induce cell cycle arrest in different phases, including human osteosarcoma cells in 
successive G(1)/S and G(2)/M phases (19) and on colorectal carcinoma cells in the 
S phase (24). Recent studies described an inhibiting growth action of curcumin by 
stimulation of adenosine 5'-monophosphate (AMP, also called activated protein 
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kinase (AMPK)) in adipocytes and cancer cells (19) and cause apoptosis in several 
cell lines (20, 21). The safety of curcumin was proved previously (17, 25- 27)  
The current study was performed to investigate the underlying molecular 
mechanism of curcumin inhibition of 3T3-L1 adipocytes. The study will aid further 
molecular signals involved in 3T3L1 adipocytes apoptosis and supports the 
potential use of Curcumin therapy in obesity resistance.  
2. MATERIALS AND METHODS 
2.1. Cell culturing and treatment. 
The 3T3-L1 cells were obtained from American Type Culture Collection 
(ATCC-CL-173) and maintained at  37°C in a 5% CO2-moistened environment. 
3T3-L1 cells were cultured in Dulbecco’s minimum essential medium (DMEM) at 
a density of 5 × 105 and supplemented with L- glutamine, 10% heat-inactivated 
fetal bovine serum (FBS), and penicillin-streptomycin (Gibco, Invitrogen 
Corporation, Carlsbad, CA, USA). After cells reached 70% confluence, Then cells  
were collected and sub cultured using a standard trypsin /EDTA method (28 - 30 ).  
Different concentrations of curcumin were dissolved in DMSO for cells treatment 
as well as with 40 µM for different periods (h). 
2.2. Cell viability assay. 
MTT ( 3-(4, 5- dimethylthiazol-2-yl)-2, 5- diphenyl tetrasodium bromide) 
reagent was used for detecting the cell death induce by curcmin treatment 
according to the previously reported method (31).  Cells were treated with 
different doses of curcumin for 24 h, followed by the addition of MTT reagents and 
finally DMSO . After discarding unbound stain, the crystalised formazan was 
dissolved and spectrophotometrically measured at 570 nm. Growth inhibition % 
was presented, with control growth as 100%, viability% was calculated  
(sample/control × 100) (32). Cell culturing was repeated to evaluate the dose-
dependent effect of curcumin using concentrations of (5, 10, 20, 
40, 60, and 80 μM) for 24 h. Ultimately, 40 μM curcumin was used to evaluate the 
time-dependent effect of treatment.  
2.3. Flow cytometric analysis of cell cycle status. 
After treatment with (40 µM) curcumin for different time periods (4, 8 ,12, 
and 24 h), cell cycle progress was examined by fluorescence-activated cell sorting 
(FACS). In brief, cells were collected by centrifugation. For fixation cells were 
vortexed slowly with 70% ethanol and kept at 4°C overnight, stained with 
propidium iodide (PI) reagents, the stained DNA content was then measured using 
a flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA) as previously 
described(29).  
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2.4. Western blotting.  
After treatment with 40 µM curcumin, the cells were washed with ice-
cold 1× phosphate-buffered saline (PBS), collected, centrifuged, and total protein 
was extracted using radioimmunoprecipitation buffer. In brief, lysis buffer were 
add to re-suspend the pellets, which were subjected to ultrasonication, and then 
centrifuged to separate cell debris. Supernatants were kept at – 20°C until use (9, 
33). Immunoblotting was carried out using antibodies against β-actin, PKA 
(ab5816, abcam, Cambridge, UK), p-CREB (9191s Cell Signaling Technology, 
Danvers, MA, USA), CREB (9197, Cell Signaling Technology), p-AMPK (2535s, Cell 
Signaling Technology), and AMPK (2532, Cell Signaling Technology) according to 
the manufacturers’ protocols. 
2.5. Protein Kinase A (PKA) phosphorylation assay.  
PKA activity was measured based on transferring 32P-ATP to a targeted 
peptide substrate. Relative PKA activity was measured with a liquid scintillation 
counter as previously described (34). 
2.6. Measurement of reactive oxygen species (ROS) generation.  
Intracellular ROS concentrations were assessed using the oxidant-sensitive 
fluorescent probe-dichloro-dihydro-fluorescein diacetate (DCFHDA. 3T3L1 cells 
were incubated with DCFHDA and then washed with 1× PBS. Fluorescence was 
measured spectrofluorometery at wavelengths (excitation 507 nm and  emission: 
530 nm) as previously described (35). 
2.7. Statistical analysis.  
Three independent experiments were carried out for the statistical 
evaluation. Data are presented as mean ± SEM. All results were generated with 
SPSS (Chicago, IL, USA) using analysis of variance (ANOVA) and Least Significant 
Difference (LSD) post-hoc tests. Values of P < 0.05 were considered significant. 
3. RESULTS 
3.1. Curcumin inhibits 3T3L1 adipocyte viability in a dose- and time-dependent 
manner. 
The cell life survival of curcumin (viability or % inhibition) was measured 
with the MTT cell viability assay post-induction and confirmation of adipocyte 
differentiation. The results revealed that treatment of 3T3L1 adipocytes for 24 h 
with different concentrations of curcumin (5, 10, 20, 40, 60, and 80 µM) in the 
culture media resulted in significant (p<0.01) and gradual inhibition in mean cell 
viability (94.76% ± 1.01%, 89.65% ± 0.65%, 84.64% ± 0.93%, 71.90% ± 1.09%, 
51.51% ± 1.42%, 28.91% ± 6.65%, respectively;  vs compared to control cell 
(viability of 100%;  (Figure 1)). 
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Figure 1.- Viability % inhibition effect of different concentrations of curcumin ( 5- 80 µM ) on 
3T3L1 adipocytes. Cells were incubated with curcumin for 24h. Viability of the cells 
calculated by formula sample/control) x100. 
 
Post-hoc testing (LSD) showed that the most significant inhibition (P ≤ 0.01) 
started from the dose of 40 µM, which is physiologically relevant. Moreover, 
induction of maximum inhibition by curcumin - as previously recommended-  at (P 
≤ 0.01) with this concentration (Figure 1). The selected dose (36- 37)  showed a 
clear gradual inhibition in 3T3L1 cell viability% in a time-dependent manner 
(Figure 2), indicating that cell viability was significantly decreased (P ≤ 0.01) with 
longer incubations (97.13% ± 0.85%, 90.42% ± 1.44%, 74.38% ± 1.87%,and 
64.12% ± 3.54% at 4, 8, 12, and 24 h, respectively). 
3.2. Curcumin induces apoptosis.  
FACS analysis provided information about the extent of cell death (%). The 
results clearly showed that curcumin (40 μM) induced apoptosis in a time-
dependent manner, indicated an increase in cell death % compared with control 
(Figure 3). 
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Figure 2.- Viability %  inhibition effect  of 40 µM curcumin for different periods ranged from 
(4-24h) on  3T3-L1 adipocytes.  Cells Viability %  was calculated by formula sample/control) 
x100.  
 
3.3. Curcumin induces AMPK and adiponectin activation and suppresses PKA 
and CREB phosphorylation.  
We next studied downstream the effect of Curcumin on these signals. 
Western blot analysis demonstrated that cells treated with 40 μM curcumin 
induced AMPK phosphorylation (p-AMPK) and reduced levels of phosphorylated 
CREB (p-CREB) and phosphorylated Akt (p-Akt, to a lesser extent). Curcumin 
increased the expression of adiponectin, however, total AMPK expression was 
unaffected. β-actin was used as a loading control (Figure 4). 
3.4. Curcumin inhibits PKA activation. 
We further demonstrated a gradual decrease with time in the expression of 
the PKA catalytic subunit, an important transcription factor. The results of the PKA 
relative phosphorylation assay support this result; PKA relative activity was 
inhibiting 4–24-h post-curcumin treatment (Figure 5B) 
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  Figure 3.- Curcumin (40 μM)  induces  apoptosis  (the number of cell death (%)) with time 
increasing. 
 
3.5. Curcumin-inhibits oxidative stress-induced apoptosis. 
 ROS relative fluorescence was measured after curcumin treatment (40 μM) 
showed an inhibitory effect on ROS generation level with/without H2O2 treatment 
of 3T3L1 adipocytes (Figure 6). 
4. DISCUSION  
This present study was performed to address contrasting data 
demonstrating that Curcumin inhibits adipogenesis in 3T3-L1 adipocytes versus 
data demonstrating that Curcumin activates proliferation of 3T3-L1 adipocytes. In 
addition, the present studies aim to elucidate the underlying molecular mechanism 
utilized by Curcumin. The results showed that increasing doses of curcumin 
significantly inhibited 3T3L1adipocyte viability%. A lot of compelling evidences 
have also shown that curcumin exerts an angio-inhibitory action by decreasing 
vascular endothelial growth factor levels of NIH3T3 cells (17). These results were 
in agreement with previous finding that curcumin inhibited differentiation and 
increased apoptosis in 3T3-L1 (16)  and in T -cell lymphoma cell lines (20). 
Curcumin can significantly decrease leptin release in LPS-treated adipocytes in 
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concentration and time-dependent way (5). The action of Curcumin observed in 
our current study is in agreement to results published by Guo and coworkers (24) 
who treated human colorectal carcinoma cells with 0–30 µg/mL curcumin and 
observed significant concentration-dependent inhibition of cell viability and 
growth, as well as induction of apoptosis. It is worth mentioning that low doses of 
curcumin (0.02 µM for 24 h) exert different actions than high doses, which can 
have cytotoxic effects on 3T3-L1 cells (22).  
 
Figure 4.- Western blot analysis showed that curcumin (40 mM) treated 3T3L1 cells at the 
indicated time induced AMPK phosphorylation (p-AMPK) and inhibited phosphorylated 
CREB (p-CREB) and also phosphorylated AKt (p-Akt) to a lesser extent . Adiponectin 
expression increased with time increasing in compartion with control. The expression 
of AMPK and CREB were still detected and didn’t differ post curcumin (40µM) treatment in 
indicated time, β – actin used as control  for protein loading 
 
Furthermore, flow cytometry analysis of cells treated with curcumin 
revealed an accumulation of apoptotic cells and suggested a clear and gradual 
increase in cell death compared with control (Figure 3). The results were in 
agreement with those published by Kim et al (38); We hypothesize that this delay 
in cell growth may be attributable to re-regulation of  the expression of some 
essential proteins required in cell cycle (39) and to the modulation in apoptotic 
factors (24). Curcumin has shown apoptotic effects in many cell lines in a 
concentration- and time-dependent manner (6). 
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Figure 5a.- Curcumin (40 µM) treatment showed clear decrease in the expression of PKA 
catalytic subunit with time increasing in 3T3L1 cells compared with control. 
 
 
Figure 5b.- Curcumin  (40 µM) treatment showed an inhibiting effect on PKA activity  (%) 
during 4-24h on 3T3L1 cells. 
 
In this study, FACS analysis showed that curcumin arrested the cell cycle. 
Curcumin was shown to  induce sequential G1/S and G2/M phase arrest in a 
human osteosarcoma cell line (37)  and S phase arrest in human colorectal 
carcinoma cells (24).Our data demonstrated found that Curcumin induced 
apoptosis and inhibited ROS generation level induced by the oxidant H2O2 in 
3T3L1 adipocytes. This result could be explained by the findings of 
Balasubramanyam et al (40) who showed that the antioxidant effects of curcumin 
occurred via inhibition of Ca2+ influx and protein kinase C. In contrast, 
Thayyullathil et al (41) reported that curcumin induced ROS generation, which in 
turn resulted in apoptosis via activating apoptotic-inducing factor in mouse 
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fibroblast L929 cells. In addition, Yang et al, (42) showed that ajoene exerts 
apoptotic activity in 3T3L1 cells by increasing intracellular ROS levels. The results 
of the current study demonstrate that curcumin exerts apoptotic effect on 3T3L1 
cells in an ROS generation-independent fashion. 
 
Figure 6.- Showed curcumin (40µM) inhibiting effect on ROS generation level induced with/ 
without  H2O2 in 3T3L1 adipocytes. 
 
Western blot analysis revealed that curcumin inhibited 3T3L1 viability and 
affected cellular signalling, including PKA pathway inhibitions, cyclic adenosine 
mono phosphate  (cAMP) is an essential intracellular second messenger for 
controlling a variety of cellular processes, and PKA is its primary target (43).  In 
this study, 40 µM curcumin increased p-AMPK levels (Figure 4) but inhibited 
expression of the PKA catalytic subunit and its relative activity (Figure 5). PKA has 
four subunits, and the dissociated active catalytic subunits elicit cellular responses 
by increasing the phosphorylation of several proteins. cAMP-mediated 
transcriptional responses requires the ability of PKA to phosphorylate CREB (30)  . 
Induction of CREB is followed by the expression of many transcription factors that 
support adipogenesis (13,44,45). To identify the physiological importance of PKA 
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signalling on the apoptotic action of curcumin, we examined the expression of PKA 
catalytic subunits in Curcumin treated 3T3L1 adipocyte cells. We demonstrated 
that Curcumin treatment blocked PKA catalytic subunit expression and inhibited 
PKA relative activity (Figure 5A), especially at 24h post treatment (Figure 5B),, 
which explained the gradual reduction in p-CREB levels (Figure 4). As Akt's 
phosphorylation is required for its efficient activation (30), the p-Akt expression 
was also examined and found that it has decreased but to a lesser extent than p-
CREB (Figure 4). This means that the apoptotic action of curcumin on 3T3L1 cells 
is accompanied by decreasing p-CREB and p-Akt expression. This is consisting with 
the function of CREB in mediating Akt’s action described by Wang et al.(46) and 
Akt’s ability to phosphorylate CREB  (47).  
In contrast, these results disagree with the finding of Yeo et al (30) studying 
prostaglandin-mediated anti-apoptotic action on monocytic HL-60 cells. 
Adiponectin hormone concentrations are inversely correlated with body fat 
% in adults (48). In transgenic mice, there was a reduction in adipocytes 
differentiation following overexpression of adiponectin targeted to adipose tissue 
(49) which is in agreement with other findings. Curcumin’s apoptotic effect was 
accompanied by increased expression of both adiponectin and p-AMPK (Figure 4). 
Adiponectin appears to be a growth antagonistic hormone in 3T3L1 adipocytes 
and may promote apoptosis via the AMPK signal pathway. AMPK has a key role in 
regulating cell metabolism, energy (50), cell growth, autophagy, and cell 
reprogramming, (12). In the current study, AMPK was detected in 3T3L1 before 
and 24-h post-curcumin treatment, a result that is supported by a previous study 
of adipocytes and cancer cells, which found that curcumin plays a critical role on 
cell differentiation and growth inhibition via AMPK activation (19, 12). 
Upregulation of fatty acid oxidation is a physiological function of leptin and 
adiponectin in skeletal muscle, and adipokines are able to carry out this function 
through their effect on AMPK signalling (51, 52). Our findings demonstrated that 
both adipokines and cAMP play a role in  apoptosis and  are supported by the study 
on breast cancer cells by Naviglio et al, (9) who concluded that although leptin 
inhibits adenylate cyclase/cAMP/PKA, elevating cAMP levels may be a novel 
therapy for breast cancer. Furthermore, Hardie et al (53) demonstrated that  
stimulators of AMPK  may be of useful tools for preventing metabolic diseases.       
In conclusion, curcumin modulates the phosphorylation of cellular 
signalling molecules. Curcumin’s ability to inhibit the phosphorylation of 
transcription factor in 3T3L1 could be attributed to the ability of AMPK to adapt to 
acute changes in the metabolic enzymes via direct phosphorylation and through 
decreased transcriptional response (54). In addition, AMPK reduced the 
expression of CREB targets (12), and Curcumin decreased the expression of the 
PKA catalytic subunit and inhibited levels of the phosphorylated protein factors p-
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CREB and p-Akt, Finally, the apoptotic effect of curcumin was synchronised with 
decreased expression of p-Akt, which is an important factor in cell survival and 
proliferation (47). 
5. ACKNOWLEDGEMENT 
The author thanks Dr Adeeb Shehzad for his technical assistance and help 
with figures preparation, and gratefully acknowledges the efforts by Prof. 
Alexzander Asea and Dr. Badaruddin Abbasi for carefully proofreading the 
manuscript. 
6. REFERENCES 
1. Elmore S. Apoptosis: A Review of Programmed Cell Death. Toxicologic Pathology 35, 495–
516 (2007). 
2. Tilg, H.; Moschen, AR. Adipocytokines, mediators linking adipose tissue, inflammation and 
immunity. Nature Reviews Immunology. 6, 772-783 (2006). 
3. Aoki, N.; Jin-no, S.; Nakagawa, Y.; Asai, N.; Arakawa, E.; Tamura, N.; Tamura, T.; Matsuda, T. 
Identification and characterization of microvesicles secreted by 3T3-L1 adipocytes, redox- 
and hormone-dependent induction of milk fat globule-epidermal growth factor 8-
associated microvesicles. JEndocrinology 148(8), 3850-3862 (2007). 
4. Zeigerer, A.; Rodeheffer, M S.; McGraw, T E.; Friedman, J M. Insulin regulates leptin secretion 
from 3T3-L1 adipocytes by a PI 3 kinase independent mechanism. JExp Cell Res. 1, 
314(11-12), 2249-2256 (2008). 
5. Ciardi, C.; Jenny, M.; Tschoner, A.; Ueberall, F.; Patsch, J.; Pedrini, M.; Ebenbichler, C.; Fuchs, 
D. Food additives such as sodium sulphite, sodium benzoate and curcumin inhibit leptin 
release in lipopolysaccharide-treated murine adipocytes in vitro. Br J Nutr 107(6), 826-
833 (2012). 
6. Jiang, M C.; Yang-Yen, H F.; Yen, J J.; Lin, J K. Curcumin induces apoptosis in immortalized NIH 
3T3 and malignant cancer cell lines. Nutr Cancer 26(1), 111-120 (1996). 
7. Peyot, M.; Gadeau, A.; Dandré, F.; Belloc, I.; Dupuch, F.; Desgranges, C. Extracellular 
Adenosine Induces Apoptosis of Human Arterial Smooth Muscle Cells via A2b-
Purinoceptor. Circulation Research 86, 76-85 (2000). 
8. Zhang, J.; Wang, Q.; Zhu, N.; Yu, M.; Shen, B.; Xiang, J.; Lin A. Cyclic AMP inhibits JNK 
activation by CREB-mediated induction of c-FLIP(L) and MKP-1, thereby antagonizing UV-
induced apoptosis. Cell Death Differ 15(10), 1654-1662 (2008). 
9. Naviglio, S.; Di Gesto, D.; Romano, M.; Sorrentino, A.; Illiano, F.; Sorvillo, L.; Abbruzzese, A.; 
Marra, M.; Caraglia, M.; Chiosi, E.; Spina, A.; Illiano, G. Leptin enhances growth inhibition by 
cAMP elevating agents through apoptosis of MDA-MB-231 breast cancer cells. Cancer 
Biology & Therapy 8(12), 1183-1190 (2009). 
10. Ruderman, N B.; Park, H.; Kaushik, V K.; Dean, D S.; Constant, S.; Prentki, M.; Saha, A K. 
AMPK as a metabolic switch in rat muscle, liver and adipose tissue after exercise. Acta 
Physiol Scand 178, 435–442 (2003). 
11. Ruderman, N. B.; Saha, A. K.; Vavvas, D.; Witters, L. A. Malonyl-CoA, fuel sensing and insulin 
resistance. Am J Physiol 276, E1–18 (1999). 
12. Mihaylova, M. M.; Shaw, R. J. The AMPK signalling pathway coordinates cell growth, 
autophagy and metabolism. Nature Cell Biology 13, 1016-1023 (2011). 
 13. Reusch, J. B.; Colton, L. A.; Klemm, D. J. CREB Activation induces adipogenesis in 3T3-L1 
cells. Mol Cell Biol 20.3, 1008–1020 (2000). 
14. Simon, H. U.; Haj-Yehia, A.; Levi-Schaffer, F. Role of reactive oxygen species (ROS) in 
apoptosis induction. Apoptosis 5.5, 415-418 (2000). 
15. Antognelli, C.; Gambelunghe, A.; Talesa, V. N.; Muzi, G. Reactive oxygen species induce 
apoptosis in bronchial epithelial BEAS-2B cells by inhibiting the antiglycation glyoxalase I 
Curcumin-induced apoptosis in 3T3L1 cells 
 
 733 
 
defence, involvement of superoxide anion.; hydrogen peroxide and NF-κB. Apoptosis 
(2013 September 4) (Epub ahead of print). 
16. Ejaz, A.; Dayong, W.; Paul, K.; Mohsen, M. Curcumn inhibits adipogenesis in 3T3-L1 
adipocytes and angiogenesis and besity in C57/BL Mice1–3. The Journal of Nutrition 139 
919–925 (2009). 
17. Gururaj, A. E.; Belakavadi, M.; Venkatesh, D. A.; Marmé, D.; Salimath, B. P. Molecular 
mechanisms of anti-angiogenic effect of curcumin. Biochem Biophys Res Commun 4, 
297(4), 934-942 (2002). 
18. Kawamori, T.; Lubet, R.; Steele, V. E.; Kelloff, G. J.; Kaskey, R. B.; Rao, C. V.; Reddy, B. S. 
Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, 
during the promotion/progression stages of colon cancer. Cancer Res 59, 597–601 (1999). 
19. Lee, YK.; Lee, W.S.; Hwang, J.T.; Kwon, D.Y.; Surh, Y.J.; Park, O.J. Curcumin exerts 
antidifferentiation effect through AMPKalpha-PPAR-gamma in 3T3-L1 adipocytes and 
antiproliferatory effect through AMPKalpha-COX-2 in cancer cells. J Agric Food Chem 14, 
57(1), 305-310 (2009a). 
20. Zhang, C.; Li, B.; Zhang, X.; Hazarika, P.; Aggarwal, B.B.; Duvic, M. Curcumin selectively 
induces apoptosis in cutaneous T-cell lymphoma cell lines and patients' PBMCs, potential 
role for STAT-3 and NF-kappaB signaling. J Invest Dermatol 130(8), 2110-2119 (2010).. 
21. Masuelli, L.; Benvenuto, M.; Fantini, M.; Marzocchella, L.; Sacchetti, P.; et al. Curcumin 
induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in 
neu transgenic mice. J Biol Regul Homeost Agents 27(1), 105-119 (2013). 
22. Kim, J H.; Park, S. H.; Nam, S. W.; Kwon, H. J.; Kim, B. W.; Kim, W. J.; Choi, Y. H. Curcumin 
stimulates proliferation, stemness acting signals and migration of 3T3-L1 preadipocytes. 
International Journal of Molecular Medicine 28(3), 429-435 (2011a). 
23. Staal, S P.; Hartley, J. W.; Rowe, W. P. Isolation of transforming murine leukemia viruses 
from mice with a high incidence of spontaneous lymphoma. Proc. Natl. Acad. Sci 74(7), 
3065–3067 (1977). 
24. Guo, L D.; Chen, X. J.; Hu, Y. H.; Yu, Z. J.; Wang, D.; Liu, J. Z. Curcumin inhibits proliferation 
and induces apoptosis of human colorectal cancer cells by activating the mitochondria 
apoptotic pathway. Phytother Res 27(3), 422-430 (2013). 
25. Ammon, H. P.; Wahl, M. A. Pharmacology of Curcuma longa. Planta Med 57, 1–7 (1991). 
26. Chainani-Wu, N. Safety and Anti-Inflammatory Activity of Curcumin, A Component of 
Tumeric (Curcuma longa). The Journal of Alternative and Complementary Medicine 9.1, 
161-168 (2003). 
27. Nawaz, A.; Khan, G.; Hussain, A.; Ahmad, A.; Khan, A.; Safdar, M. Gomal. University Journal 
of Research 27(1), 7-14 (2011). 
28. Lu, F.; Chen, H.; Zhou, C.; Liu, S.; Guo, M.; Chen, P.; Zhuang, H.; Xie, D.; Wu, S. T-type Ca2+ 
channel expression in human esophageal carcinomas, A functional role in proliferation. 
Cell Calcium 43(1), 49–58 (2008). 
 29. Lee, S.; Shehzad, A.; Jung, J.; Sonn, J.; Lee, J.; Park, J.; Lee, S. Protein kinase Cα protects 
against multidrug resistance in human colon cancer cells. Molecules and Cells 34(1), 61-
69 (2012). 
30. Yeo, H.; Shehzad, A.; Lee, Y. Prostaglandin E2 Blocks Menadione-Induced Apoptosis 
through the Ras/Raf/Erk Signaling Pathway in Promonocytic Leukemia Cell Lines. 
Molecules and Cells 33, 371-378 (2012). 
31. Hsu; Yen. Posted without published information on the link 
http,//www.nchu.edu.tw/~add/budget/student%20abroad/inter-meeting-94/T94-3-
27.pdf 
32. Hsu, C.; Yen, G. Induction of cell apoptosis in 3T3-L1 pre-adipocytes by flavonoids is 
associated with their antioxidant activity. Molecular Nutrition & Food Research 50(11), 
1072–1079 (2006). 
 33. Reyes-Leon, A.; Atherton, J C.; Argent, R H. Puente, J. L.; Torres V. Heterogeneity in the 
Activity of Mexican Helicobacter pylori Strains in Gastric Epithelial Cells and Its 
Association with Diversity in the cagA Gene. Infect. Immun 75(7), 3445-3454 (2007). 
34. Blum, S.; Moore, A N.; Adams, F.; Dash, P K. A mitogen-activated protein kinase cascade in 
the CA1/CA2 subfield of the dorsal hippocampus is essential for long-term spatial 
memory. J. Neurosci 19, 3535-3544 (1999). 
35. Roy, A.; Ganguly, A.; Dasgupta, S. B.; Das, B. B.; Pal, C.; Jaisankar, P.; Majumder H. K. 
Mitochondria-Dependent Reactive Oxygen Species-Mediated Programmed Cell Death 
734 
 
Induced by 3.;3_-Diindolylmethanethrough Inhibition of F0F1-ATP Synthase in Unicellular 
Protozoan Parasite Leishmania donovani. Molecular Pharmacology 74(5), 1292-1307 
(2008). 
36. Wang, D.; Jiang, H. U.; Lin, L. V.; Xiuwen, X.I.A..; Jianzhong, L.I.U.; Xiaoyuan, L.I. Enhanced 
inhibitory effect of curcumin via reactive oxygen species generation in human 
nasopharyngeal carcinoma cells following purple-light irradiation. Oncology Letters 6(1), 
81–85 (2013). 
37. Lee, D. S.; Lee, M. K.; Kim, J. H. Curcumin induces cell cycle arrest and apoptosis in human 
osteosarcoma (HOS) cells. Anticancer research 29, 5039-5044 (2009b). 
38. Kim, CY.; Le, T. T.; Cheng, J.; Kim, K. Curcumin inhibits adipocyte differentiation through 
modulation of mitotic clonal expansion. The Journal of Nutritional Biochemistry 22(10), 
910-920 (2011b). 
39. Bertoli, C.; Skotheim, J. M.; De Bruin, R.A.M. Control of cell cycle transcription during G1 and 
S phases Nature Reviews. Molecular Cell Biology 14, 518- 528 (2013). 
40. Balasubramanyam, M.; Koteswari, A. A.; Kumar, R. S.; Monickaraj, S. F.; Maheswari, J U.; 
Mohan, V. Curcumin-induced inhibition of cellular reactive oxygen species generation, 
Novel therapeutic implications. J. Biosci 28, 715–721 (2003). 
41. Thayyullathil, F.; Shahanas, C.; Abdulkader, H.; Mahendra, P.; Sehamuddin, G. Rapid 
reactive oxygen species (ROS) generation induced by curcumin leads to caspase-
dependent and -independent apoptosis in L929 cells. Free Radical Biology and Medicine 
45(10), 1403–1412 (2008). 
42. Yang, J.; Della-Fera, M. A.; Nelson-Dooley, C.; Baile, C. A. Molecular Mechanisms of Apoptosis 
Induced by Ajoene in 3T3-L1 Adipocytes. Obesity 14(3), 388–397 (2006). 
43. Funamoto, S.; Anjard, C.; Nellen, W.; Ochiai, H. cAMP-dependent protein kinase regulates 
Polysphondylium pallidum development. Differentiation 71(1), 51-61 (2003). 
44. Voet, V.; Pratt. Fundamentals of Biochemistry. Wiley; 2006. 
45. Peverelli,E.; Ermetici, F.; Corbetta, S.; Gozzini, E.; Avagliano, L.; Zappa, M.; Bulfamante G.; 
Beck-Peccoz, P.; Spada, A.; Mantovani G. PKA regulatory subunit R2B is required for 
murine and human adipocyte differentiation. Endocr Connec EC-13-0049, (2006). 
46. Wang, J. M; Chao, J. R.; Chen, W.; Kuo, M L.; Yen, J J.; Yang-Yen, H F. The antiapoptotic gene 
mcl-1 is up-regulated by the phosphatidylinositol 3-kinase/Akt signaling pathway through 
a transcription factor complex containing CREB. Mol. Cell Bio 19, 6195-7206 (1999). 
47. Song, G.; Ouyang, G.; Bao, S. The activation of Akt/PKB signaling pathway and cell survival. 
Journal of Cellular and Molecular Medicine 9(1), 59–71 (2005). 
48. Ukkola, O.; Santaniemi, M. Adiponectin: a link between excess adiposity and associated 
comorbidities? J. Mol. Med 80(11), 696–702 (2002).. 
49. Bauche, I B.; El Mkadem, S A.; Pottier, A. M.; Senou, M.; Many, M. C.; Rezsohazy, R.; Penicaud, 
L.; Maeda, N.; Funahashi, T.; Brichard, S M. Overexpression of adiponectin targeted to 
adipose tissue in transgenic mice: impaired adipocyte differentiation. Endocrinology 148, 
1539–1549 (2007). 
50. Zhang, B. B.; Zhou, G.; Li, C. AMPK, an emerging drug target for diabetes and the metabolic 
syndrome. Cell Metab 5, 407-416 (2009). 
51. Minokoshi, Y.; Kim, Y. B.; Peroni, O. D.; Fryer, L. G.; Müller, C.; Carling. D.; Kahn, BB. Leptin 
stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415 
(6869), 339–343 (2002). 
52. Taylor, E B.; Hurst, D.; Greenwood, L J.; Lamb, J D.; Cline, T D.; Sudweeks, S N.; Winder, W W. 
Endurance training increases LKB1 and MO25 protein but not AMP-activated protein 
kinase kinase activity in skeletal muscle. Am. J. Physiol. Endocrinol. Metab 287(6), E1082- 
E1089 (2004). 
53. Hardie, D. G.; Ross, F A.; Hawley, S A. AMP-activated protein kinase, a target for drugs both 
ancient and modern. Chem Biol 26,19(10), 1222-1236 (2012). 
54. Cantó, C.; Auwerx, J. AMP-activated protein kinase and its downstream transcriptional 
pathways. Cell Mol Life Sci 67(20), 3407-3423 (2010).  
